GKOS vs MRNA · rev $336.2M vs rev $145.0M
Glaukos Corp (GKOS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Glaukos Corp (GKOS) is a medical devices company listed on NYSE.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported GKOS revenue for 2026-06-30 was $336.2M. Net income was -$38.2M. GKOS currently screens at market cap $7.63B.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
GKOS currently screens at market cap $7.63B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the GKOS and MRNA stock pages for the full models.
Not investment advice.